BlackRock Health Sciences Opportunities Portfolio Investor A Shares (SHSAX) - Health fund with $6.37 Billion in assets. The fund allocates 41.82% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is UNITEDHEALTH GROUP INC at 3.54% of total assets. This is followed by ELI LILLY CO (7.46%) and BOSTON SCIENTIFIC CORP (4.66%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 3.54% | - | - |
| ELI LILLY CO | 7.46% | - | - |
| BOSTON SCIENTIFIC CORP | 4.66% | - | - |
| AMGEN INC | 3.26% | - | - |
| THERMO FISHER SCIENTIFIC INC | 3.53% | - | - |
| INTUITIVE SURGICAL INC | 5.34% | - | - |
| Danaher Corp | 3.35% | - | - |
| AbbVie Inc | 3.97% | - | - |
| ELEVANCE HEALTH INC | 2.99% | - | - |
| STRYKER CORP | 3.72% | - | - |
| ABBOTT LABORATORIES | 5.90% | - | - |
| GILEAD SCIENCES INC | 2.91% | - | - |
| Johnson Johnson | 8.37% | - | - |
| Medtronic PLC | 3.37% | - | - |
| Eli Lilly Co | 10.89% | - | - |
| Abbott Laboratories | 5.03% | - | - |
| Thermo Fisher Scientific Inc | 3.69% | - | - |
| UnitedHealth Group Inc | 3.57% | - | - |
| Amgen Inc | 3.41% | - | - |
| Gilead Sciences Inc | 2.94% | - | - |
| Intuitive Surgical Inc | 2.75% | - | - |
| Eli Lilly Co. COM | 11.34% | - | - |
| Johnson Johnson COM | 10.22% | - | - |
| AbbVie Inc. COM | 4.11% | - | - |
| Gilead Sciences Inc. COM | 3.96% | - | - |
| Merck Co., Inc COM | 3.55% | - | - |
| Amgen Inc. COM | 3.49% | - | - |
| UnitedHealth Group Inc. COM | 3.04% | - | - |
| Intuitive Surgical Inc. COM NEW | 2.46% | - | - |
| Abbott Laboratories COM | 2.43% | - | - |
| Danaher Corporation COM | 2.31% | - | - |
| ELI LILLY COMPANY COM | 12.29% | - | - |
| JOHNSON JOHNSON COM | 8.77% | - | - |
| UNITEDHEALTH GROUP INC COM | 6.10% | - | - |
| MERCK COMPANY INC COM | 4.94% | - | - |
| GILEAD SCIENCES INC COM | 4.19% | - | - |
| ABBVIE INC COM | 3.94% | - | - |
| AMGEN INC COM | 3.37% | - | - |
| THERMO FISHER SCIENTIFIC INC COM | 3.02% | - | - |
| VERTEX PHARMACEUTICALS INC COM | 2.74% | - | - |
| PFIZER INC COM | 2.61% | - | - |